Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

New Ultrasound Contrast Delivery System Garners FDA 510(k) Clearance

11 August 2026 · By · Wire by Fusion42

Published

11 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at diagnosticimaging.com →

◆ Verified

Fusion42 · 12 August 2026 · Fusion42 review

The VueJect ultrasound contrast delivery system designed for cardiac ultrasound imaging has received FDA 510(k) clearance and Health Canada authorization.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Medtech founders in cardiac ultrasound now have a market entry unlocked in the US and Canada. You should prioritise linking with clinical users who value improved ultrasound contrast delivery as the approval eases adoption barriers.

◆ Coverage

1 source · 11 Aug 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancecardiac-ultrasoundcontrast-deliveryhealth-canadamedical-device